Abstract
To determine the therapeutic usefulness of benzimidazoles in trichinellosis, 117 patients from a single outbreak were treated either with albendazole alone (N=59) or with a regimen including tiabendazole followed by flubendazole (N=58). The criteria of disease activity were evaluated at days 1, 7, 15, and 45. No difference was found between the two groups with regard to the evolution of myalgia, fever, fatigue, new clinical manifestations, or laboratory and serologic data. Both treatment regimens were well tolerated. In all, 30 patients of the albendazole group and 29 of the tiabendazole-flubendazole group were reevaluated 16 months later. Serology was negative in 70% of the albendazole-treated patients vs 34.5% of the tiabendazole-flubendazole-treated patients (P<0.01). The muscle biopsy examination of nine patients suggested less parasitic infection in the albendazole group. In conclusion, no difference was noted during the early therapeutic responses to the drugs used, but albendazole might be more effective than the other regimen in treating residual larval infestation estimated 16 months after the onset of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ancelle T, Dupouy-Camet J, Heyer F, Faurant C, Lapierre J, Parham G, Leese W, Leighty JC (1986) Horsemeat-associated trichinosis — France. MMWR 35:291–298
Andy JJ, O'Connel JP, Daddario RC, Roberts WC (1977) Trichinosis causing extensive ventricular mural endocarditis with superimposed thrombosis. Am J Med 63:824–829
Bouréc P, Bouvier JP, Passeron J, Galanaud P, Dormont J (1979) Outbreak of trichinosis near Paris. Br Med J 1:1047–1049
Brown HD, Matzuk AR, Ilves IR, Peterson LH, Harris SA, Sarret LH, Egerton JR, Campbell WC, Cuckler AC (1961) Antiparasitic drugs: IV. 2-(4′-Thiazolyl)-Benzimidazole. a new anthelmintic. J Am Chem Soc 83:1764–1765
Campbell WC, Denham DA (1983) Chemotherapy. In: Campbell WC (ed) Trichinella and trichinosis. Plenum, New York, pp 359–360
Dalessio DJ, Wolff HG (1961)Trichinella spiralis infection of the central nervous system. Report of a case and review of the literature. Arch Neurol 4:407–417
Davis MJ, Cilo M, Plaitakis A, Yahr M (1976) Trichinosis: severe myopathic involvement with recovery. Neurology 26:37–40
Frayha RA (1981) Trichinosis-related polyarteritis nodosa. Am J Med 71:307–312
Gay T, Pankey GA, Beckman EN, Washington P, Bell KA (1982) Fatal CNS trichinosis. JAMA 247:1024–1025
Gerwel C, Pawlowski Z (1975) Advances in the treatment of trichinellosis. Wiad Parazytol 11:527–528
Gould SE (1970) Clinical manifestation: A. Symptomatology. In: Gould SE (ed) Trichinosis in man and animals. C. Thomas, Springfield, pp 269–306
Gray DF, Morse BS, Philipps WF (1962) Trichinosis with neurologic and cardiac involvement. Review of the literature and report of three cases. Ann Intern Med 57:230–244
Hall WI, McCabe (1967) Trichinosis. Report of a small outbreak with observations of thiabendazole therapy. Arch Intern Med 119:65–68
Horstmann RD, Kern P, Volkmer KJ, Dietrich M (1982) Observation on mebendazole vs. thiabendazole in the treatment of human trichinellosis. Tropenmed Parasitol 33:191–194
Kassur B, Januszkiewicz J (1968) Clinical classification of trichinosis. Epidemiol Rev 22:134–139
Kean BH, Hoskins DW (1964) Treatment of trichinosis with thiabendazole. A preliminary report. JAMA 190:852–853
Kramer MD, Aita JF (1978) Trichinosis. In: Vinken JP, Bruyn GW (eds) Handbook of clinical neurology. North Holland, Amsterdam, pp 267–290
Levin ML (1983) Treatment of trichinosis with mebendazole. Am J Trop Med Hyg 5:980–983
Ljunström I (1983) Immunodiagnosis in man. Protocol for indirect immunofluorescence. In: Campbell WC (ed) Trichinella and trichinosis. Plenum, New York, pp 416–420
McCracken RO (1978) Efficacy of mebendazole and albendazole againstTrichinella spiralis in mice. J Parasitol 2:214–219
Mittermayer T, Spaldonova R, (1981) The use of mebendazole in the treatment of trichinellosis in man. Folia Parasitol (Prague) 28:235–242
Neafie RC, Connor DH (1976) Trichinosis. In: Binford CH, Connor DH (eds) Pathology of tropical and extraordinary diseases vol 2. Armed Forces Institute of Pathology, Washington DC, pp 409–414
Pawlowski Z (1983) Clinical aspects in man. In: Campbell WC (ed) Trichinella and trichinosis. Plenum, New York, pp 394–396
Pawlowski ZS (1986) Trichinellosis. In: Braude AI (ed) Infectious disease and medical microbiology, 2nd edn. WB Saunders, Philadelphia, pp 1536–1539
Rossignol JF, Coulaud JP (1983) Summary of clinical trials world-wide. In: Firth M (ed) evaluation of albendazole in Europe, West Africa and Asia as a single dose helminthiasis. Royal Society of Medicine International Congress Symposium. Series No 57. Academic Press, London, pp 19–30
Saimot AG, Meulemans A, Grimeux AC, Giovangeli MD, Hay JM, Delaitre B, Coulard JP (1983) Albendazole as a potential treatment for human hydatidosis. Lancet ii:652–656
Spaeth GL, Adams RE, Soffe AM (1964) Treatment of trichinosis. Case report. Arch Ophthalmol 71:359–363
Tanowitz MB, Wittner M (1970) Probable thiabendazole allergy after repeated administration. J Trop Med Hyg 73:141–142
Webster LT (1985) Drugs used in the chemotherapy of helminthiasis. In: Gilman AG, Goodman AS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. MacMillan, New York, pp 1004–1023
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fourestié, V., Bougnoux, M.E., Ancelle, T. et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res 75, 36–41 (1988). https://doi.org/10.1007/BF00931188
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00931188